Scott K. Thompson - Concepedia

Author

Scott K. Thompson

Also Known As

D.E. Blair, S K Thompson, S Thompson, S. K. THOMPSON, S. K. Thompson, S. Thompson, S.K. Thompson, SCOTT K. THOMPSON, Scott K. Thompson, Scott Thompson

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)New Frontier Research Triangle Park Foundation South College University of Rochester Medical Center

About

Scott K. Thompson is an author at GlaxoSmithKline (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	26	1.4K
2	Natural Sciences	14	14	1K
3	Engineering	2	2	113
4	Health Sciences	1	1	27
5	Public Health	1	1	148

Scott K. Thompson

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Proteolytic Activity of Human Osteoclast Cathepsin K Mary J. Bossard, Thaddeus A. Tomaszek, Scott K. Thompson, Journal of Biological Chemistry	1996	488
Development of a Small-Molecule Serum- and Glucocorticoid-Regulated Kinase-1 Antagonist and Its Evaluation as a Prostate Cancer Therapeutic Andrea B. Sherk, Daniel E. Frigo, Christine G. Schnackenberg, Cancer Research	2008	207
4-Aryl-1,2,3-triazole: A Novel Template for a Reversible Methionine Aminopeptidase 2 Inhibitor, Optimized To Inhibit Angiogenesis in Vivo Lara S. Kallander, Qing Lü, Wenfang Chen, Journal of Medicinal Chemistry Mouse Matrigel ModelEndothelial Cell GrowthPharmacotherapyChemical BiologyPharmaceutical Chemistry	2005	188
Peptide Aldehyde Inhibitors of Cathepsin K Inhibit Bone Resorption Both In Vitro and In Vivo Bartholomew J. Votta, Mark A. Levy, Alison M. Badger, Journal of Bone and Mineral Research SclerostinBiochemistryBone Morphogenic ProteinMedicineNatural Sciences	1997	185
A Structural and in Vitro Characterization of Asoprisnil: A Selective Progesterone Receptor Modulator Kevin P. Madauss, Eugene T. Grygielko, Su-Jun Deng, Molecular Endocrinology Vitro CharacterizationHormonal ContraceptiveProgesterone ReceptorGynecologyReproductive Biology	2007	148
Design of potent and selective human cathepsin K inhibitors that span the active site Scott K. Thompson, Stacie M. Halbert, Mary J. Bossard, Proceedings of the National Academy of Sciences Bioorganic ChemistryAldo-keto ReductaseMolecular BiologyChemical BiologyMedicinal Chemistry	1997	119
Synthetic LXR agonists increase LDL in CETP species Pieter H.E. Groot, John Yates, Claire J. Stocker, Journal of Lipid Research	2005	116
Structure and Design of Potent and Selective Cathepsin K Inhibitors Dennis S. Yamashita, Ward W. Smith, Baoguang Zhao, Journal of the American Chemical Society Molecular RecognitionMolecular PharmacologyMedicinal ChemistryProtein BiochemistryBiochemistry	1997	106
External auditory canal foreign body removal: Management practices and outcomes Scott K. Thompson, Richard O. Wein, Paul O. Dutcher The Laryngoscope	2003	91
Use of Papain as a Model for the Structure-Based Design of Cathepsin K Inhibitors: Crystal Structures of Two Papain−Inhibitor Complexes Demonstrate Binding to S‘-Subsites Judith M. LaLonde, Baoguang Zhao, Ward W. Smith, Journal of Medicinal Chemistry Bioorganic ChemistryBone ResorptionAldo-keto ReductaseMolecular BiologyChemical Biology	1998	77

Page 1